Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
9.19
+0.16 (1.77%)
May 22, 2026, 4:00 PM EDT - Market closed

Vir Biotechnology Revenue

Vir Biotechnology had revenue of $-29.00K in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to $65.50M, up 213.96% year-over-year. In the year 2025, Vir Biotechnology had annual revenue of $68.56M, down -7.61%.

Revenue (ttm)
$65.50M
Revenue Growth
+213.96%
P/S Ratio
23.66
Revenue / Employee
$178,460
Employees
367
Market Cap
1.55B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202568.56M-5.65M-7.61%
Dec 31, 202474.21M-11.98M-13.90%
Dec 31, 202386.18M-1.53B-94.67%
Dec 31, 20221.62B520.38M47.51%
Dec 31, 20211.10B1.02B1,334.40%
Dec 31, 202076.37M68.28M843.86%
Dec 31, 20198.09M-2.58M-24.16%
Dec 31, 201810.67M7.96M293.94%
Dec 31, 20172.71M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Novavax596.34M
Ardelyx427.68M
Immunocore Holdings412.81M
AbCellera Biologics79.21M
Immatics43.00M
Precigen31.60M
uniQure18.09M
AtaiBeckley3.49M
Revenue Rankings